Comments

MiMedx Group Stock Guidance

MDXGNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$7.25

0.131.83%

At close: Dec 16, 4:00 PM EST

$7.25

N/A

After Hours: 4:00 PM EST

Overview News Earnings Options

Guidance

Analyst Ratings Insider Trades Short Interest Stock Report

MiMedx Group Stock Guidance | NASDAQ:MDXG | Benzinga

MiMedx Group issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
01/09/2023	MDXG	MiMedx Group	FY	2022	—	—	—	$266.00M	$269.00M	$268.00M	Get Alert
01/09/2023	MDXG	MiMedx Group	Q4	2022	—	—	—	$73.00M	$76.00M	$74.53M	Get Alert
11/02/2022	MDXG	MiMedx Group	FY	2022	—	—	—	$266.00M	$269.00M	$267.53M	Get Alert
11/02/2022	MDXG	MiMedx Group	Q4	2022	—	—	—	$73.00M	$76.00M	$75.02M	Get Alert
02/28/2022	MDXG	MiMedx Group	FY	2022	—	—	—	$266.40M	$273.60M	$267.30M	Get Alert

FAQ

Q

What is the most recent guidance for MiMedx Group (MDXG)?

A

There have been no specific sales or earnings guidance reported for MiMedx Group in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

ARS Pharmaceuticals Inc

MoonLake Immunotherapeutics

Tyra Biosciences Inc

Monte Rosa Therapeutics Inc